1. Home
  2. OMH vs CLGN Comparison

OMH vs CLGN Comparison

Compare OMH & CLGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ohmyhome Limited

OMH

Ohmyhome Limited

N/A

Current Price

$4.58

Market Cap

4.6M

Sector

Finance

ML Signal

N/A

Logo CollPlant Biotechnologies Ltd

CLGN

CollPlant Biotechnologies Ltd

SELL

Current Price

$4.49

Market Cap

5.2M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
OMH
CLGN
Founded
2015
2004
Country
Singapore
Israel
Employees
N/A
N/A
Industry
Real Estate
Industrial Specialties
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.6M
5.2M
IPO Year
2022
2015

Fundamental Metrics

Financial Performance
Metric
OMH
CLGN
Price
$4.58
$4.49
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 7.9M
38.4K
Earning Date
09-10-2026
11-25-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$39.14
N/A
Revenue Next Year
$145.74
$25.00
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.06
$0.26
52 Week High
$94.60
$4.78

Technical Indicators

Market Signals
Indicator
OMH
CLGN
Relative Strength Index (RSI) 47.61 61.49
Support Level $1.00 $0.34
Resistance Level N/A $4.64
Average True Range (ATR) 14.69 0.40
MACD -0.19 -0.01
Stochastic Oscillator 1.99 86.92

Price Performance

Historical Comparison
OMH
CLGN

About OMH Ohmyhome Limited

Ohmyhome Ltd is a data and technology-driven property technology company based in Singapore. Through its subsidiaries, it operates a one-stop-shop property platform that provides end-to-end property solutions and services for its customers, which comprises brokerage services and emerging and other services, such as home renovation and furnishing services, listing and research, mortgage referral, legal services, and insurance referral services. The company derives its revenues from two sources: revenue from brokerage services, property management services, Digital Marketing Services, and emerging and other services. The firm operates in two segments, which are Brokerage, emerging and another related service; and Estate management services and other related services in Singapore.

About CLGN CollPlant Biotechnologies Ltd

CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives majority revenue, Canada, Europe and Other, and Israel.

Share on Social Networks: